In the highly competitive biotech industry, only a few standout companies attract Wall Street’s attention. Among them, two high-growth biotech stocks, Axsome Therapeutics (AXSM) and Viking Therapeutics (VKTX), have analysts predicting massive upside ahead. These companies not only promise breakthroughs in neuroscience and metabolic disease, but they may also help deliver massive returns to investors who are willing to ride the wave. Let’s find out why Wall Street is so bullish.
